148 related articles for article (PubMed ID: 27276112)
1. Loss of CDKN2A Promoter Methylation Coincides With the Epigenetic Transdifferentiation of Uterine Myosarcomatous Cells.
Roncati L; Barbolini G; Sartori G; Siopis E; Pusiol T; Maiorana A
Int J Gynecol Pathol; 2016 Jul; 35(4):309-15. PubMed ID: 27276112
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.
Binh MB; Guillou L; Hostein I; Château MC; Collin F; Aurias A; Binh BN; Stoeckle E; Coindre JM
Am J Surg Pathol; 2007 Oct; 31(10):1557-66. PubMed ID: 17895758
[TBL] [Abstract][Full Text] [Related]
3. Uterine composite tumor composed of leiomyosarcoma and embryonal rhabdomyosarcoma with immature cartilage.
Verma M; Joseph G; McCluggage WG
Int J Gynecol Pathol; 2009 Jul; 28(4):338-42. PubMed ID: 19483631
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss.
Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA
Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of the CDKN2C (p18INK4c) gene product in pituitary adenomas.
Kirsch M; Mörz M; Pinzer T; Schackert HK; Schackert G
Genes Chromosomes Cancer; 2009 Feb; 48(2):143-54. PubMed ID: 18973139
[TBL] [Abstract][Full Text] [Related]
6. Clinical Benefit in Response to Palbociclib Treatment in Refractory Uterine Leiomyosarcomas with a Common
Elvin JA; Gay LM; Ort R; Shuluk J; Long J; Shelley L; Lee R; Chalmers ZR; Frampton GM; Ali SM; Schrock AB; Miller VA; Stephens PJ; Ross JS; Frank R
Oncologist; 2017 Apr; 22(4):416-421. PubMed ID: 28283584
[TBL] [Abstract][Full Text] [Related]
7. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus.
Bian YS; Osterheld MC; Fontolliet C; Bosman FT; Benhattar J
Gastroenterology; 2002 Apr; 122(4):1113-21. PubMed ID: 11910361
[TBL] [Abstract][Full Text] [Related]
8. Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.
Schaefer IM; Hornick JL; Sholl LM; Quade BJ; Nucci MR; Parra-Herran C
Histopathology; 2017 Jun; 70(7):1138-1146. PubMed ID: 28130839
[TBL] [Abstract][Full Text] [Related]
9. P16, Ki67, P53, and WT1 Expression in Uterine Smooth Muscle Tumors: An Adjunct in Confirming the Diagnosis of Malignancy in Ambiguous Cases.
Delgado B; Dreiher J; Braiman D; Meirovitz M; Shaco-Levy R
Int J Gynecol Pathol; 2021 May; 40(3):257-262. PubMed ID: 32897968
[TBL] [Abstract][Full Text] [Related]
10. [Detection of methylation status of p16 tumor suppressor gene in soft tissue leiomyosarcoma].
Xu J; Yang G; Bu H; Guo L; Zhang S; Liu J
Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):16-8. PubMed ID: 11866950
[TBL] [Abstract][Full Text] [Related]
11. [Progress in clinicopathologic study on uterine smooth muscle tumor of uncertain malignant potential].
Deng ZJ; Guo LN
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):573-6. PubMed ID: 22169655
[No Abstract] [Full Text] [Related]
12. Amplification of CDK4, MDM2, SAS and GLI genes in leiomyosarcoma, alveolar and embryonal rhabdomyosarcoma.
Ragazzini P; Gamberi G; Pazzaglia L; Serra M; Magagnoli G; Ponticelli F; Ferrari C; Ghinelli C; Alberghini M; Bertoni F; Picci P; Benassi MS
Histol Histopathol; 2004 Apr; 19(2):401-11. PubMed ID: 15024701
[TBL] [Abstract][Full Text] [Related]
13. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
14. Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.
Rushing RS; Shajahan S; Chendil D; Wilder JL; Pulliam J; Lee EY; Ueland FR; van Nagell JR; Ahmed MM; Lele SM
Gynecol Oncol; 2003 Oct; 91(1):9-14. PubMed ID: 14529657
[TBL] [Abstract][Full Text] [Related]
15. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
16. Myocardin functions as an effective inducer of growth arrest and differentiation in human uterine leiomyosarcoma cells.
Kimura Y; Morita T; Hayashi K; Miki T; Sobue K
Cancer Res; 2010 Jan; 70(2):501-11. PubMed ID: 20068148
[TBL] [Abstract][Full Text] [Related]
17. Frequent occurrence of loss of heterozygosity among tumor suppressor genes in uterine leiomyosarcoma.
Zhai YL; Nikaido T; Orii A; Horiuchi A; Toki T; Fujii S
Gynecol Oncol; 1999 Dec; 75(3):453-9. PubMed ID: 10600306
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
[TBL] [Abstract][Full Text] [Related]
19. Metastatic Uterine Leiomyosarcoma With Rhabdomyosarcomatous Heterologous Differentiation.
Boyraz B; Gogakos T; Raskin KA; Nielsen GP
Int J Gynecol Pathol; 2023 Mar; 42(2):151-154. PubMed ID: 35348494
[TBL] [Abstract][Full Text] [Related]
20. Germline
Jouenne F; Chauvot de Beauchene I; Bollaert E; Avril MF; Caron O; Ingster O; Lecesne A; Benusiglio P; Terrier P; Caumette V; Pissaloux D; de la Fouchardière A; Cabaret O; N'Diaye B; Velghe A; Bougeard G; Mann GJ; Koscielny S; Barrett JH; Harland M; Newton-Bishop J; Gruis N; Van Doorn R; Gauthier-Villars M; Pierron G; Stoppa-Lyonnet D; Coupier I; Guimbaud R; Delnatte C; Scoazec JY; Eggermont AM; Feunteun J; Tchertanov L; Demoulin JB; Frebourg T; Bressac-de Paillerets B
J Med Genet; 2017 Sep; 54(9):607-612. PubMed ID: 28592523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
